Clinical Trial Update: A Trial Comparing the Efficacy and Tolerability of Faslodex With Nolvadex in Postmenopausal Women With Advanced Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial comparing fulvestrant (Faslodex) to tamoxifen (Nolvadex) in postmenopausal women with advanced/metastatic breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Faslodex (fulvestrant)
• Nolvadex (tamoxifen)

Snippet

Sponsor: AstraZeneca | Conditions: Breast Cancer, Metastasis | Phase 3 | Status: COMPLETED